Funding for this research was provided by:
Gilead Sciences (IN-ES-131-4501)
Received: 6 October 2020
Accepted: 6 January 2021
First Online: 22 January 2021
Ethics approval and consent to participate
: The Research Ethics Committee with Medicines from Vall d’Hebron Research Institute (Barcelona, Spain) approved the study in March 2018 (code VAL-ANT-2017-01). The referred committee granted permission to access and analyse the study data. Patients’ data was anonymised before its use. Study participants consent to participate is not applicable.
: Not Applicable.
: The authors declare that they have no competing interests.